Oscar fell in its stock-market debut


Today in healthcare news: Oscar fell in its stock-market debut, inside DispatchHealth’s latest (short!) pitch deck that it used to reach a $US1.7 ($2) billion valuation, and the data is in on how vaccine work outside clinical trials.

Mario schlosser oscar health
Mario Schlosser, CEO and co-founder of Oscar speaks to guests during the TechCrunch Disrupt event in Manhattan, in New York City, NY, U.S. May 15, 2017. Eduardo Munoz/Reuters

Oscar Health, the original buzzy health-insurance startup, fell 11% in its IPO. We pored over its 215-page filing to find 4 key takeaways.

Read the full story from Shelby Livingston here>>

Dispatch health 2
DispatchHealth clinicians treat patients in their own homes. Nathan Hindman/DispatchHealth

We got an exclusive look at the presentation that convinced Tiger Global and Humana to invest in a startup’s bold vision to do hospitalizations at home at a $US1.7 ($2) billion valuation

Read the full story from Blake Dodge and Megan Hernbroth here>>

Pfizer vial
The arrival of coronavirus vaccines means people have started hawking so-called ‘vaccines’ on the Dark Web. CHRIS JACKSON/POOL/AFP via Getty Images

The data is in: COVID-19 vaccines are proving to be crucial in curbing the pandemic by slashing infections, hospitalizations, and deaths

Read the full story from Andrew Dunn here>>

More stories we’re reading:

– Lydia